Skip to main content

Sofinnova Investments, Inc.

Position in ROIV — Roivant Sciences Ltd.

CIK 1631134 Menlo Park, CA

Position in ROIV

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$13,240,461
-$2,699,968 QoQ
Shares Held
477,995
-34.9% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Derivatives in ROIV

reported options exposure · as of Jun 30, 2025
CallValue
$11,270,000
CallShares
1,000,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ROIV

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,240,461 477,995
2025-12-31 $15,940,429 734,582
2025-09-30 $47,648,455 3,149,270
2025-06-30 $11,270,000 1,000,000
2025-06-30 $34,810,933 3,088,814
2025-03-31 $12,910,255 1,279,510
2024-06-30 $19,749,114 1,868,412
2024-03-31 $10,557,960 1,001,704